Skip to main content
Erschienen in: Cancer Causes & Control 7/2013

01.07.2013 | Original paper

Cancer incidence and mortality of Surinamese migrants in the Netherlands: in-between Surinamese and Dutch levels?

verfasst von: Graciëlle Williams, Dennis R. A. Mans, Joop Garssen, Otto Visser, Daniëlle Kramer, Anton E. Kunst

Erschienen in: Cancer Causes & Control | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

It has been suggested that the cancer risk of migrants from low-income to high-income countries will converge toward the levels of their host country. However, comparisons with country of origin are mostly lacking. We compared cancer incidence and mortality rates of Surinamese migrants in the Netherlands to both native Dutch and Surinamese levels.

Methods

Data covering the period 1995–2008 were obtained from Surinamese and Dutch national cancer registries and national cause-of-death registries. Cancer incidence was studied for 21 types of cancer and cancer mortality for nine types. We calculated age-standardized incidence/mortality ratios (SIR/SMR) for the Surinamese migrants and for Suriname, using the native Dutch population as reference.

Results

Significantly lower overall cancer incidence (SIR = 0.77, 95 % CI = 0.69–0.84) and mortality rates (SMR = 0.63, 95 % CI = 0.55–0.72) were found for Surinamese migrants compared to native Dutch. Generally, cancer risk was lower for most cancers (e.g., cancer of the breast, colon and rectum, lung), but higher for other cancers (e.g., cancer of the uterine cervix, liver). For most cancers, cancer risk of the Surinamese migrants was in-between Surinamese and native Dutch levels. Importantly, for many cancers, migrants’ incidence and mortality rates had not closely approached native Dutch rates. For skin cancer, incidence levels for Surinamese migrants were lower than both Surinamese and native Dutch levels.

Conclusions

The results suggest that cancer incidence and mortality rates of Surinamese migrants generally converge from Surinamese toward Dutch levels, though not for all cancer types. Overall, Surinamese migrants still had a much more favorable cancer profile than the native Dutch population.
Literatur
1.
Zurück zum Zitat Jemal A, Center MM, DeSantis C (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomark Prev 19:1893–1907CrossRef Jemal A, Center MM, DeSantis C (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomark Prev 19:1893–1907CrossRef
2.
Zurück zum Zitat Arnold M, Razum O, Coebergh JW (2010) Cancer risk diversity in non-western migrants to Europe: an overview of the literature. Eur J Cancer 46:2647–2659PubMedCrossRef Arnold M, Razum O, Coebergh JW (2010) Cancer risk diversity in non-western migrants to Europe: an overview of the literature. Eur J Cancer 46:2647–2659PubMedCrossRef
3.
Zurück zum Zitat Parkin DM, Khlat M (1996) Studies of cancer in migrants: rational and methodology. Eur J Cancer 32:761–771CrossRef Parkin DM, Khlat M (1996) Studies of cancer in migrants: rational and methodology. Eur J Cancer 32:761–771CrossRef
4.
Zurück zum Zitat Stirbu I, Kunst AE, Vlems FA, Visser O, Bos V, Deville W, Nijhuis HGJ, Coebergh JW (2006) Cancer mortality rates among first and second generation migrants in The Netherlands: convergence toward the rates of the native Dutch population. Int J Cancer 119:2665–2672PubMedCrossRef Stirbu I, Kunst AE, Vlems FA, Visser O, Bos V, Deville W, Nijhuis HGJ, Coebergh JW (2006) Cancer mortality rates among first and second generation migrants in The Netherlands: convergence toward the rates of the native Dutch population. Int J Cancer 119:2665–2672PubMedCrossRef
5.
Zurück zum Zitat Fang J, Madhavan S, Alderman MH (1996) Cancer mortality of Chinese in New York City 1988–1992. Int J Epidemiol 25:907–912PubMedCrossRef Fang J, Madhavan S, Alderman MH (1996) Cancer mortality of Chinese in New York City 1988–1992. Int J Epidemiol 25:907–912PubMedCrossRef
6.
Zurück zum Zitat Shimizu H, Ross RK, Bernstein L (1991) Cancers of the breast and prostate among Japanese and white immigrants in Los Angeles Country. Br J Cancer 63:963–966PubMedCrossRef Shimizu H, Ross RK, Bernstein L (1991) Cancers of the breast and prostate among Japanese and white immigrants in Los Angeles Country. Br J Cancer 63:963–966PubMedCrossRef
7.
Zurück zum Zitat Harding S, Rosatob M, Teyhan A (2009) Trends in cancer mortality among migrants in England and Wales, 1979–2003. Eur J Cancer 45:2168–2179PubMedCrossRef Harding S, Rosatob M, Teyhan A (2009) Trends in cancer mortality among migrants in England and Wales, 1979–2003. Eur J Cancer 45:2168–2179PubMedCrossRef
8.
Zurück zum Zitat Spallek J, Arnold M, Hentschel S, Razum O (2009) Cancer incidence rate ratios of Turkish immigrants in Hamburg, Germany: a registry based study. Cancer Epidemiol 33:413–418PubMedCrossRef Spallek J, Arnold M, Hentschel S, Razum O (2009) Cancer incidence rate ratios of Turkish immigrants in Hamburg, Germany: a registry based study. Cancer Epidemiol 33:413–418PubMedCrossRef
9.
Zurück zum Zitat Harding S (2004) Mortality of migrants from the Caribbean to England and Wales: effect of duration of residence. Int J Epidemiol 33:382–386PubMedCrossRef Harding S (2004) Mortality of migrants from the Caribbean to England and Wales: effect of duration of residence. Int J Epidemiol 33:382–386PubMedCrossRef
10.
Zurück zum Zitat Visser O, van Leeuwen FE (2007) Cancer risk in first generation migrants in North-Holland/Flevoland, The Netherlands, 1995–2004. Eur J Cancer 43:901–908PubMedCrossRef Visser O, van Leeuwen FE (2007) Cancer risk in first generation migrants in North-Holland/Flevoland, The Netherlands, 1995–2004. Eur J Cancer 43:901–908PubMedCrossRef
11.
Zurück zum Zitat Wild S, Mckeigue P (1997) Cross sectional analysis of mortality by country of birth in England and Wales, 1970–92. Br Med J 314:705–710CrossRef Wild S, Mckeigue P (1997) Cross sectional analysis of mortality by country of birth in England and Wales, 1970–92. Br Med J 314:705–710CrossRef
12.
Zurück zum Zitat McCredie M (1998) What have we learned from the studies of migrants. Cancer Causes Control 9:1–2PubMedCrossRef McCredie M (1998) What have we learned from the studies of migrants. Cancer Causes Control 9:1–2PubMedCrossRef
13.
Zurück zum Zitat McMichael AJ, Giles GG (1998) Cancer in migrants to Australia: extending the descriptive epidemiological data. Cancer Res 48:751–756 McMichael AJ, Giles GG (1998) Cancer in migrants to Australia: extending the descriptive epidemiological data. Cancer Res 48:751–756
14.
Zurück zum Zitat Nicolaas H, Wobma E, Ooijevaar J (2010) Demografie van (niet-westerse) allochtonen in Nederland. In: van der Vliet R, Ooijevaar J, Boerdam A (eds) Jaarrapport integratie 2010. Statistics Netherlands, The Hague Nicolaas H, Wobma E, Ooijevaar J (2010) Demografie van (niet-westerse) allochtonen in Nederland. In: van der Vliet R, Ooijevaar J, Boerdam A (eds) Jaarrapport integratie 2010. Statistics Netherlands, The Hague
15.
Zurück zum Zitat Bindraban NR, Stronks K, Klazinga NS (2003) Cardiovasculaire risicofactoren bij Surinamers in Nederland: een literatuuroverzicht. Ned Tijdschr Geneeskd 147:1591–1594PubMed Bindraban NR, Stronks K, Klazinga NS (2003) Cardiovasculaire risicofactoren bij Surinamers in Nederland: een literatuuroverzicht. Ned Tijdschr Geneeskd 147:1591–1594PubMed
16.
Zurück zum Zitat Agyemang C, Stronks K, Tromp N, Bhopal R, Zaninotto P, Unwin N, Nazroo J, Kunst AE (2010) A cross-national comparative study of smoking prevalence and cessation between English and Dutch South Asian and African origin populations; the role of national context. Nicotine Tob Res 12:557–566PubMedCrossRef Agyemang C, Stronks K, Tromp N, Bhopal R, Zaninotto P, Unwin N, Nazroo J, Kunst AE (2010) A cross-national comparative study of smoking prevalence and cessation between English and Dutch South Asian and African origin populations; the role of national context. Nicotine Tob Res 12:557–566PubMedCrossRef
17.
Zurück zum Zitat Grulich AE, McCredie M, Coates M (1995) Cancer incidence in Asian migrants tot New South Wales, Australia. Br J Cancer 71:400–408PubMedCrossRef Grulich AE, McCredie M, Coates M (1995) Cancer incidence in Asian migrants tot New South Wales, Australia. Br J Cancer 71:400–408PubMedCrossRef
18.
Zurück zum Zitat Thomas DB, Karagas MR (1987) Cancer in first and second generation Americans. Cancer Res 47:5771–5776PubMed Thomas DB, Karagas MR (1987) Cancer in first and second generation Americans. Cancer Res 47:5771–5776PubMed
19.
Zurück zum Zitat Marmot MG, Adelstein AM, Bulusu L (1984). Lessons from the study of immigrant mortality. The Lancet 1455–1457 Marmot MG, Adelstein AM, Bulusu L (1984). Lessons from the study of immigrant mortality. The Lancet 1455–1457
20.
Zurück zum Zitat Shai D (1991) Cancer mortality in Cuba and among the Cuban-Born in the United States: 1979–1981. Public Health Rep 106:68–73PubMed Shai D (1991) Cancer mortality in Cuba and among the Cuban-Born in the United States: 1979–1981. Public Health Rep 106:68–73PubMed
21.
Zurück zum Zitat McCredie M, Williams S, Coates M (1999) Cancer Mortality in East and Southeast Asian migrants to New South Wales, Australia, 1975–1995. Int J Cancer 83:179–185PubMedCrossRef McCredie M, Williams S, Coates M (1999) Cancer Mortality in East and Southeast Asian migrants to New South Wales, Australia, 1975–1995. Int J Cancer 83:179–185PubMedCrossRef
22.
Zurück zum Zitat Zeeb H, Razum O, Blettner M, Stegmaier C (2002) Transition in cancer patterns among Turks residing in Germany. Eur J Cancer 38:705–711PubMedCrossRef Zeeb H, Razum O, Blettner M, Stegmaier C (2002) Transition in cancer patterns among Turks residing in Germany. Eur J Cancer 38:705–711PubMedCrossRef
23.
Zurück zum Zitat Winkler V, Ott JJ, Holleczek B, Stegmaier C, Becher H (2009) Cancer profile of migrants from the former soviet union in Germany: incidence and mortality. Cancer Causes Control 20:1873–1879PubMedCrossRef Winkler V, Ott JJ, Holleczek B, Stegmaier C, Becher H (2009) Cancer profile of migrants from the former soviet union in Germany: incidence and mortality. Cancer Causes Control 20:1873–1879PubMedCrossRef
24.
Zurück zum Zitat Van der Sanden GA, Coebergh JWW, Schouten LJ, Visser O, van Leeuwen FE (1995) Cancer incidence in The Netherlands in 1989 and 1990. First results of the nationwide Netherlands Cancer Registry. Eur J Cancer 31:1822–1829CrossRef Van der Sanden GA, Coebergh JWW, Schouten LJ, Visser O, van Leeuwen FE (1995) Cancer incidence in The Netherlands in 1989 and 1990. First results of the nationwide Netherlands Cancer Registry. Eur J Cancer 31:1822–1829CrossRef
25.
Zurück zum Zitat Mans DRA, Rijkaard E, Dollart J et al (2008) Differences between urban and rural areas of the Republic of Suriname in the ethnic and age distribution of cancer—a retrospective study from 1980 through 2004. Open Epidemiol J 1:30–35CrossRef Mans DRA, Rijkaard E, Dollart J et al (2008) Differences between urban and rural areas of the Republic of Suriname in the ethnic and age distribution of cancer—a retrospective study from 1980 through 2004. Open Epidemiol J 1:30–35CrossRef
26.
Zurück zum Zitat Punwasi W (2009) Doodsoorzaken in Suriname 2007. Public Health Agency, Paramaribo Punwasi W (2009) Doodsoorzaken in Suriname 2007. Public Health Agency, Paramaribo
27.
Zurück zum Zitat World Health Organization (2010) International statistical classification of diseases and related health problems, 10th revision. World Health Organization, Geneva World Health Organization (2010) International statistical classification of diseases and related health problems, 10th revision. World Health Organization, Geneva
28.
Zurück zum Zitat Ulm K (1990) A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). Am J Epidemiol 131:373–375PubMed Ulm K (1990) A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). Am J Epidemiol 131:373–375PubMed
29.
Zurück zum Zitat General Bureau of Statistics, Census Office (2006) Census 2004 coverage evaluation. General Bureau of Statistics, Census Office General Bureau of Statistics, Census Office (2006) Census 2004 coverage evaluation. General Bureau of Statistics, Census Office
30.
Zurück zum Zitat Uitenbroek DG, Verhoeff AP (2002) Life expectancy and mortality differences between migrant groups living in Amsterdam, The Netherlands. Soc Sci Med 54:1379–1388PubMedCrossRef Uitenbroek DG, Verhoeff AP (2002) Life expectancy and mortality differences between migrant groups living in Amsterdam, The Netherlands. Soc Sci Med 54:1379–1388PubMedCrossRef
31.
Zurück zum Zitat Bos V, Kunst AE, Keij-Deerenberg IM, Garssen J, Mackenbach JP (2004) Ethnic inequalities in age-and cause-specific mortality in The Netherlands. Int J Epidemiol 33:1112–1119PubMedCrossRef Bos V, Kunst AE, Keij-Deerenberg IM, Garssen J, Mackenbach JP (2004) Ethnic inequalities in age-and cause-specific mortality in The Netherlands. Int J Epidemiol 33:1112–1119PubMedCrossRef
32.
Zurück zum Zitat Stirbu I, Kunst AE, Bos V, Mackenbach JP (2006) Differences in avoidable mortality between migrants and the native Dutch in The Netherlands. BMC Public Health 27:78CrossRef Stirbu I, Kunst AE, Bos V, Mackenbach JP (2006) Differences in avoidable mortality between migrants and the native Dutch in The Netherlands. BMC Public Health 27:78CrossRef
33.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRef Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRef
34.
Zurück zum Zitat Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137–2150PubMedCrossRef Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137–2150PubMedCrossRef
35.
Zurück zum Zitat Nierkens V, van der Vloeg MV, van Eer MY, Stronks K (2011) How do psychosocial determinants in migrant women in the Netherlands differ from these among their countersparts in their country of irigin? A cross-sectional study. BMC Public Health 11:397PubMedCrossRef Nierkens V, van der Vloeg MV, van Eer MY, Stronks K (2011) How do psychosocial determinants in migrant women in the Netherlands differ from these among their countersparts in their country of irigin? A cross-sectional study. BMC Public Health 11:397PubMedCrossRef
36.
Zurück zum Zitat Visser O, van der Kooy K, van Peppen AM, Öry FG, van Leeuwen FE (2004) Breast cancer risk among first-generation migrants in The Netherlands. Br J Cancer 90:2135–2137PubMed Visser O, van der Kooy K, van Peppen AM, Öry FG, van Leeuwen FE (2004) Breast cancer risk among first-generation migrants in The Netherlands. Br J Cancer 90:2135–2137PubMed
37.
Zurück zum Zitat Fracheboud J, Otto SJ, Van Dijck JA, Broeders MJ, Verbeek AL, De Koning HJ, National Evaluation Team for Breast Cancer Screening (NETB) (2004) Decreased rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer 91:861–867PubMed Fracheboud J, Otto SJ, Van Dijck JA, Broeders MJ, Verbeek AL, De Koning HJ, National Evaluation Team for Breast Cancer Screening (NETB) (2004) Decreased rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer 91:861–867PubMed
38.
39.
Zurück zum Zitat Lefkowitz ES, Garland CF (1994) Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol 23:1133–1136PubMedCrossRef Lefkowitz ES, Garland CF (1994) Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol 23:1133–1136PubMedCrossRef
40.
Zurück zum Zitat Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP (2007) Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85:1586–1591PubMed Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP (2007) Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85:1586–1591PubMed
41.
Zurück zum Zitat International Association for Medical Assistance to Travellers (IAMAT) (2010) World Schistosomiasis Risk Chart. IAMAT, Toronto International Association for Medical Assistance to Travellers (IAMAT) (2010) World Schistosomiasis Risk Chart. IAMAT, Toronto
42.
Zurück zum Zitat Bosch X, Ribes J, Díaz M, Cléries R (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127:5–16CrossRef Bosch X, Ribes J, Díaz M, Cléries R (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127:5–16CrossRef
43.
Zurück zum Zitat Van Dijk MG (2008) Thesis on Hepatitis B in Suriname. Prince Leopold institute of tropical medicine, Antwerp Van Dijk MG (2008) Thesis on Hepatitis B in Suriname. Prince Leopold institute of tropical medicine, Antwerp
Metadaten
Titel
Cancer incidence and mortality of Surinamese migrants in the Netherlands: in-between Surinamese and Dutch levels?
verfasst von
Graciëlle Williams
Dennis R. A. Mans
Joop Garssen
Otto Visser
Daniëlle Kramer
Anton E. Kunst
Publikationsdatum
01.07.2013
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 7/2013
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-013-0217-x

Weitere Artikel der Ausgabe 7/2013

Cancer Causes & Control 7/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.